Concepedia

Kaori Yuki

KY

Statistics

Publications

4

Citations

314

H-Index

4

Active since

2013

Affiliations

Chiba University(Current)

King's College Hospital

Kaori Yuki is an author at Chiba University specializing in tumor biology, cancer research, and medicine.

Top concepts

Publications per year

2013–2017

4

Publications

4

Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma

Tetsuhiro Chiba, Tomoko Saito, Kaori Yuki et al. · International Journal of Cancer · 2014 · 116 citations · Full text

, , +21

Disulfiram Eradicates Tumor-Initiating Hepatocellular Carcinoma Cells in ROS-p38 MAPK Pathway-Dependent and -Independent Manners

Tetsuhiro Chiba, Eiichiro Suzuki, Kaori Yuki et al. · PLoS ONE · 2014 · 78 citations · Full text

Metformin, a Diabetes Drug, Eliminates Tumor-Initiating Hepatocellular Carcinoma Cells

Tomoko Saito, Tetsuhiro Chiba, Kaori Yuki et al. · PLoS ONE · 2013 · 73 citations · Full text

Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma

Masayuki Yokoyama, Tetsuhiro Chiba, Yoh Zen et al. · Oncotarget · 2017 · 47 citations · Full text

, , +23

1–4 of 4